I agree that this site is using cookies. You can find further informations here.
X
Kersting, Sabina
73  results:
Search for persons X
?
1

S148: TIME-LIMITED VENETOCLAX AND IBRUTINIB FOR PATIENTS WI..:

Kater, Arnon ; Dubois, Julie ; Brieghel, Christian...
HemaSphere.  7 (2023)  S3 - p. e10648ed , 2023
Link: https://doi.org/10.1097/..
 
?
2

S144: BTK AND BCL-2 ACTIVITY AT BASELINE PREDICTS MRD STATU..:

Urban, Aleksandra ; Hermansen, Johanne ; Yin, Yanping...
HemaSphere.  7 (2023)  S3 - p. e92046ec , 2023
Link: https://doi.org/10.1097/..
 
?
3

Immunogenicity of the 13-Valent Pneumococcal Conjugated Vac..:

Haggenburg, Sabine ; Garcia Garrido, Hannah M. ; Kant, Iris M. J....
Vaccines.  11 (2023)  7 - p. 1201 , 2023
Link: https://doi.org/10.3390/..
 
?
4

P1523: IMMUNOGENICITY OF THE 13-VALENT PNEUMOCOCCAL CONJUGA..:

Haggenburg, Sabine ; Garrido, Hannah Garcia ; Kant, Iris...
HemaSphere.  7 (2023)  S3 - p. e8157636 , 2023
Link: https://doi.org/10.1097/..
 
?
5

S140: IBRUTINIB SENSITIZES CLL CELLS TO VENETOCLAX BY INTER..:

Kielbassa, Karoline ; Haselager, Marco ; Bax, Danique...
HemaSphere.  7 (2023)  S3 - p. e7227685 , 2023
Link: https://doi.org/10.1097/..
 
?
6

Ibrutinib sensitizes CLL cells to venetoclax by interruptin..:

Kielbassa, Karoline ; Haselager, Marco V. ; Bax, Danique J. C....
Leukemia.  37 (2023)  6 - p. 1268-1276 , 2023
Link: https://doi.org/10.1038/..
 
?
7

P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIR..:

Kersting, Sabina ; Levin, Mark-David ; Dubois, Julie...
HemaSphere.  7 (2023)  S3 - p. e797861a , 2023
Link: https://doi.org/10.1097/..
 
?
8

P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND ..:

Hengeveld, Paul ; Schilperoord-Vermeulen, Joyce ; van der Klift, Michèle...
HemaSphere.  7 (2023)  S3 - p. e639493f , 2023
Link: https://doi.org/10.1097/..
 
?
9

Protocol description of the HOVON 141/VISION trial: a prosp..:

Levin, Mark-David ; Kater, Arnon ; Mattsson, Mattias...
BMJ Open.  10 (2020)  10 - p. e039168 , 2020
Link: https://doi.org/10.1136/..
 
?
10

Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia ..:

Slot, Stefanie ; Raymakers, Reinier A.P. ; Schaap, Nicolaas...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. 624-634 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Distinct immune composition in lymph node and peripheral bl..:

Kater, Arnon P. ; Tonino, Sanne H. ; Eldering, Eric...
Blood Advances.  3 (2019)  17 - p. 2642-2652 , 2019
Link: https://doi.org/10.1182/..
 
?
12

Clinical Practice Guidelines for Diagnosis and Treatment of..:

Kersting, Sabina ; Neppelenbroek, Suzanne I.M. ; Visser, Hein P.J....
Clinical Lymphoma Myeloma and Leukemia.  18 (2018)  1 - p. 52-57 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Obinutuzumab pretreatment abrogates tumor lysis risk while ..:

Kater, Arnon P. ; Kersting, Sabina ; van Norden, Yvette...
Blood Advances.  2 (2018)  24 - p. 3566-3571 , 2018
Link: https://doi.org/10.1182/..
 
?
14

Primary intraocular lymphoma in a patient with systemic lup..:

Woei-A-Jin, Feng Jung S. H. ; Kersting, Sabina ; Bollemeijer, Jan Geert
Annals of Hematology.  91 (2012)  11 - p. 1821-1822 , 2012
Link: https://doi.org/10.1007/..
 
?
15

Successful Outcome after Nonmyeloablative Allogeneic Hemato..:

Kersting, Sabina ; Verdonck, Leo F.
Biology of Blood and Marrow Transplantation.  14 (2008)  11 - p. 1312-1316 , 2008
Link: https://doi.org/10.1016/..
 
1-15